CBLL Form 4: Erica J. Rogers Granted 25,216 Restricted Stock Units

Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) director Erica J. Rogers was granted 25,216 restricted stock units (RSUs) on 09/17/2025. The RSUs are reported at a $0 transaction price, and following the grant she is shown as beneficially owning 25,216 shares on a direct basis. The Form 4 was signed on behalf of Ms. Rogers by attorney-in-fact Louisa Daniels on 09/19/2025. The filing identifies Ms. Rogers as a director and indicates this is a single-person Form 4 filing for the issuer Ceribell, Inc., ticker CBLL. No derivative securities or other transactions are reported in this filing.

Insights

Financial Analyst

TL;DR: Director received 25,216 RSUs, a routine equity grant that modestly aligns interests with shareholders.

The grant of 25,216 restricted stock units to a director is a non-cash equity award intended to provide alignment with shareholder interests. The reported transaction price of $0 indicates these are compensation awards rather than open-market purchases. For investors, this is a routine corporate governance action and not a liquidity or capital-structure event. The filing contains no sales, option exercises, or derivative activity that would affect immediate share count beyond the reported beneficial ownership.

Corporate Governance Expert

TL;DR: Typical director compensation: RSUs granted and reported via Form 4; no red flags in the disclosure.

The disclosure names Erica J. Rogers as a director and documents a grant of 25,216 RSUs, reported as direct beneficial ownership. The Form 4 was executed by an attorney-in-fact and includes the standard explanatory note that the units represent restricted stock units. There is no indication of accelerated vesting, related-party sales, or unusual transaction codes. As presented, the filing is consistent with routine director equity compensation practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rogers Erica J.

(Last) (First) (Middle)

C/O CERIBELL, INC.

360 N PASTORIA AVE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		A		25,216(1)	A	$0	25,216(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 25,216 restricted stock units.

	/s/ Louisa Daniels, Attorney-in-Fact for Erica J. Rogers	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Erica J. Rogers report on Form 4 for Ceribell (CBLL)?

She reported a grant of 25,216 restricted stock units (RSUs) on 09/17/2025, showing beneficial ownership of 25,216 shares.

Was the RSU grant reported as a purchase at market price?

No. The transaction is reported with a $0 price, indicating these RSUs were granted as compensation.

What is Erica Rogers' relationship to Ceribell in the filing?

The Form 4 identifies Erica J. Rogers as a Director of Ceribell, Inc.

When was the Form 4 signed and by whom?

The Form 4 was signed by Louisa Daniels, Attorney-in-Fact for Erica J. Rogers on 09/19/2025.

Does the filing show any derivative transactions or stock sales by Ms. Rogers?

No. The filing reports only the RSU grant and lists no derivative securities or dispositions.